Clinical Trial Update: A Study to Compare Uliledlimab Combined With Sintilimab and Chemotherapy Versus Sintilimab Combined With Chemotherapy in Patients With Previously Untreated Locally Advanced Unresectable or Metastatic Non-small Cell Lung Cancer [Phase 2]

View source ↗

Summary

This clinical trial update reports a Phase 2 study comparing Uliledlimab plus Sintilimab and chemotherapy versus Sintilimab plus chemotherapy in previously untr…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Drugs mentioned

• Sintilimab (sintilimab)
• Uliledlimab (uliledlimab)

Snippet

Sponsor: TJ Biopharma Co., Ltd. | Conditions: Non Small Cell Lung Cancer | Phase 2 | Status: ACTIVE_NOT_RECRUITING